Uncategorized

Alpine Immune Sciences Announces Pricing of $150 Million Public Offering

Alpine Immune Sciences, Inc. (Nasdaq: ALPN) today announced the pricing of its underwritten public offering of 8,800,000 shares of its common stock and, in lieu of shares of common stock to certain investors, pre-funded warrants to purchase up to 3,200,000 shares of its common stock, pursuant to its existing shelf registration statement.

Alpine Immune Sciences Announces Pricing of $150 Million Public Offering Read More »

Scroll to Top